MICHELE YU: Open Payments
NPI 1003939935 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 55 payments from 14 companies in 2025. Trend: 2023 $113 · 2024 $620 · 2025 $2,076
Food & beverage: $1,547Travel & lodging: $430Education: $99
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 32 | $1,478 |
| Actelion Pharmaceuticals US, Inc. | 4 | $140 |
| Boston Scientific Corporation | 1 | $87 |
| CVRx, Inc. | 2 | $63 |
| SCPHARMACEUTICALS INC. | 3 | $58 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| PFIZER INC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Lilly USA, LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: CARDIOMEMS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, OPSUMIT, WATCHMAN Access System, Barostim Neo System, FUROSCIX, VERQUVO, VYNDAQEL.
Industry payments across MO — which companies pay providers there.
